Trilipix™ (fenofibric acid) Capsule, Delayed Release For Oral Use is indicated as adjunct to diet as combination therapy with statins for patients with mixed dyslipidemia or as monotherpy for patients with severe hypertriglyceridemia, primary hyperlipidemia or mixed dyslipidemia. Recommended initial dose: 45mg to 135mg once daily. Recommended daily dose range: 45mg to 135mg once daily. Active Ingredients: fenofibric acid.
Product Category:
Cholesterol ManagementSub-category:
Cholesterol MedicationsProduct Features:
- Contact manufacturer for further details
Other Features:
How Supplied/Sizing:
Delayed release capsule: 45mg, 135mg. 90 per bottle.
Company information:
- Street:
- Pharmaceutical Products Division
- Additional:
- 100 Abbott Park Rd.
- City:
- Abbott Park ,
- Province:
- Illinois
- Postal Code:
- 60064-3500
- Country:
- United States
Broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health.
Website:
www.abbott.com
Phone:
847-937-6100